Sort
39,280 grants matching “leukemia”
Novel targeted therapy for treating Ovarian Cancer
$639,397Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$639,187Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
$639,187Ross L Levine · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Integration of germline and tumor genomes in CLL
$639,092Susan L Slager · Mayo Clinic Rochester · R01 · FY2021 · CA
Integration of germline and tumor genomes in CLL
$639,092Susan L Slager · Mayo Clinic Rochester · R01 · FY2020 · CA
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
$638,919Logan G Spector · University Of Minnesota · R01 · FY2024 · CA
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$638,869Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
An Automated Platform for Kinase Assays on Patient Cells
$638,869University Of California Irvine · R01 · FY2004 · EB
Administrative and Informatics
$638,827Thomas J. Kipps · University Of California, San Diego · P01 · FY2012 · CA
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
$638,661Cristina Maria Fernandez-Valle · University Of Central Florida · R01 · FY2021 · DC
Development of a Phenotype-based Predictive Analytic for Acute Myeloid Leukemia
$638,605Michael R Savona · Vanderbilt University Medical Center · R01 · FY2024 · CA
Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations
$638,281Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Dissecting innate immune signaling in pre-leukemia evolution
$638,243Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · CA
Pre Pilot Project
$638,226Reynold Enriquez · University Of Puerto Rico Med Sciences · U54 · FY2011 · CA
Development of novel selective Rac inhibitors for refractory leukemias
$638,223David A Williams · Boston Children'S Hospital · R01 · FY2016 · CA
Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance
$638,188Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2018 · CA
Genomics of childhood acute lymphoblastic leukemia in the Childhood Cancer and Leukemia International Consortium
$638,157Logan G Spector · University Of Minnesota · R01 · FY2022 · CA
Non-canonical Wnt-Receptor Signaling and Targeted Therapies
$638,151Thomas J. Kipps · University Of California, San Diego · R01 · FY2021 · CA
Molecular and cellular mechanisms of neuronal damage caused by anticancer therapies
$638,067Joseph G Duman · Baylor College Of Medicine · R01 · FY2024 · CA
Therapy-related leukemia following autologous transplantation for lymphoma
$638,056Smita Bhatia · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
$637,988Lydia B Zablotska · University Of California, San Francisco · R01 · FY2019 · CA
Socioeconomic determinants of childhood cancer outcomes in a large contemporary cohort
$637,935Erin Marcotte · University Of Minnesota · R01 · FY2025 · CA
Novel patient biomarkers and mechanisms of TKI associated Cardiotoxicity
$637,883Daniel Addison · Ohio State University · R01 · FY2023 · HL
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML
$637,871Ann-Kathrin Eisfeld · Ohio State University · R01 · FY2023 · CA
New retroviral restriction factor
$637,751Tatyana V. Golovkina · University Of Chicago · R01 · FY2018 · AI